跳至主要内容
临床试验/NCT06609382
NCT06609382已完成不适用

Prognostic Value of Left Ventricular Mass Index in Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy

Changrong Nie1 个研究点 分布在 1 个国家目标入组 490 人开始时间: 2011年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
490
试验地点
1
主要终点
All-cause death

研究概览

简要总结

In this study, we aimed to analyze the association between left ventricular mass index and clinical outcomes to provide the potential indicator for worse survival.

详细描述

This retrospective study aimed to determine the prognostic value of left ventricular mass index in predicting clinical outcomes, including all-cause death, new-onset or recurrent atrial fibrillation, and a composite endpoint of all-cause death, heart failure,permanent pacemaker implantation, new-onset or recurrent atrial fibrillation, and stroke.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) Difficulty in relieving symptoms with medication or recurrent syncope. (2) Left ventricular outflow tract (LVOT) pressure gradient ≥ 50 mmHg at rest or with provocation and the maximum thickness of the septum is ≧ 15 mm.

排除标准

  • (1) Combined right ventricular outflow tract obstruction requiring right ventricular outflow tract dissection. (2) Combined mitral or aortic valve organic lesions requiring valve replacement surgery. (3) Apical ventricular aneurysm formation requiring ventriculotomy. (4) Previous septal reduction therapy, including alcohol ablation or septal myectomy. (5) patients did not undergo cardiac magnetic resonance examination.

结局指标

主要结局

All-cause death

时间窗: One month after discharge

Any death observed one month after discharge.

次要结局

  • composite endpoint(One month after discharge)

研究者

发起方
Changrong Nie
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Changrong Nie

MD

Chinese Academy of Medical Sciences, Fuwai Hospital

研究点 (1)

Loading locations...

相似试验